Schonfeld Strategic Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-271,654
Closed -$5.12M 2285
2024
Q4
$5.12M Sell
271,654
-236,082
-46% -$4.45M 0.03% 462
2024
Q3
$7.64M Buy
+507,736
New +$7.64M 0.05% 313
2024
Q1
Sell
-100,053
Closed -$3.38M 2097
2023
Q4
$3.38M Buy
+100,053
New +$3.38M 0.02% 576
2023
Q3
Sell
-102,823
Closed -$4.12M 1978
2023
Q2
$4.12M Buy
+102,823
New +$4.12M 0.04% 540
2023
Q1
Sell
-29,472
Closed -$1.14M 2401
2022
Q4
$1.14M Sell
29,472
-5,213
-15% -$201K 0.01% 1066
2022
Q3
$1.85M Sell
34,685
-3,082
-8% -$164K 0.02% 898
2022
Q2
$2.2M Buy
+37,767
New +$2.2M 0.02% 665
2021
Q4
Sell
-118,970
Closed -$6.66M 2249
2021
Q3
$6.66M Buy
118,970
+51,381
+76% +$2.88M 0.07% 327
2021
Q2
$4.1M Buy
67,589
+42,026
+164% +$2.55M 0.04% 486
2021
Q1
$1.79M Buy
+25,563
New +$1.79M 0.02% 669
2020
Q4
Sell
-13,100
Closed -$788K 1746
2020
Q3
$788K Buy
+13,100
New +$788K 0.02% 733
2020
Q2
Sell
-10,967
Closed -$368K 1441
2020
Q1
$368K Buy
+10,967
New +$368K 0.02% 676
2019
Q4
Sell
-82,200
Closed -$3.13M 1413
2019
Q3
$3.13M Buy
82,200
+12,600
+18% +$480K 0.09% 228
2019
Q2
$3.03M Buy
69,600
+10,200
+17% +$444K 0.11% 225
2019
Q1
$2.26M Sell
59,400
-39,611
-40% -$1.51M 0.08% 305
2018
Q4
$4.26M Buy
+99,011
New +$4.26M 0.16% 172
2018
Q2
Sell
-55,731
Closed -$1.74M 903
2018
Q1
$1.74M Buy
+55,731
New +$1.74M 0.13% 226
2017
Q3
Sell
-5,962
Closed -$284K 718
2017
Q2
$284K Sell
5,962
-6,864
-54% -$327K 0.03% 493
2017
Q1
$585K Buy
+12,826
New +$585K 0.06% 343
2016
Q3
Sell
-40,447
Closed -$1.36M 506
2016
Q2
$1.36M Buy
+40,447
New +$1.36M 0.31% 86